N, K., V, K., & MK, A. (2024). Neuronal toxicity of monoclonal antibodies (mAbs): An analysis of post-marketing reports from FDA Adverse Event Reporting System (FAERS) safety database. European journal of clinical pharmacology, 80(11), 1685. https://doi.org/10.1007/s00228-024-03727-0
Chicago Style (17th ed.) CitationN, Kumar, Kalaiselvan V, and Arora MK. "Neuronal Toxicity of Monoclonal Antibodies (mAbs): An Analysis of Post-marketing Reports from FDA Adverse Event Reporting System (FAERS) Safety Database." European Journal of Clinical Pharmacology 80, no. 11 (2024): 1685. https://doi.org/10.1007/s00228-024-03727-0.
MLA (9th ed.) CitationN, Kumar, et al. "Neuronal Toxicity of Monoclonal Antibodies (mAbs): An Analysis of Post-marketing Reports from FDA Adverse Event Reporting System (FAERS) Safety Database." European Journal of Clinical Pharmacology, vol. 80, no. 11, 2024, p. 1685, https://doi.org/10.1007/s00228-024-03727-0.